Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-51,591
Closed -$40.2M 53
2025
Q2
$40.2M Buy
+51,591
New +$40.1M 4.75% 7
2024
Q4
Sell
-3,659
Closed -$3.24M 55
2024
Q3
$3.24M Sell
3,659
-21,324
-85% -$19.2M 0.45% 40
2024
Q2
$22.6M Buy
24,983
+442
+2% +$354K 3.68% 10
2024
Q1
$19.1M Buy
24,541
+24,538
+817,933% +$17.5M 2.94% 15
2023
Q4
$1.75K Sell
3
-49,338
-100% -$28.8M ﹤0.01% 30
2023
Q3
$26.5M Buy
49,341
+3
+0% +$1.55K 8.36% 2
2023
Q2
$23.1M Buy
49,338
+27,931
+130% +$11.7M 6.72% 3
2023
Q1
$7.35M Buy
+21,407
New +$7.22M 2.6% 17

Other funds holding LLY

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's LLY Position: Q3 2025 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 51,591 shares — an estimated $40.2M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in LLY in Q1 2023 and held it in 8 quarters. The position peaked at $40.2M in Q2 2025. 3,899 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 51,591 Eli Lilly shares in Q3 2025, an estimated $40.2M.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Eli Lilly in Q1 2023 and held it in 8 quarters.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Eli Lilly position peaked at $40.2M in Q2 2025.
  • 3,899 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q3 2025, filed 12 Nov 2025.